2015
|
Invention
|
Tetrahydronaphthyridine derivatives as mglur2-negative allosteric modulators, compositions, and t... |
|
Invention
|
Hiv protease inhibitors. The present invention is directed to 2,6-morpholine derivatives of Formu... |
2014
|
Invention
|
Thiazole-substituted aminoheteroaryls as spleen tyrosine kinase inhibitors. The invention provide... |
|
Invention
|
Hiv protease inhibitors. The present invention is directed to 5-heteroarylmorpholine derivatives ... |
|
Invention
|
Hiv protease inhibitors. The present invention is directed to 2,5,6-substituted morpholine deriva... |
2013
|
Invention
|
Triazolyl derivatives as syk inhibitors. Provided are triazole derivatives of Formula I which are... |
|
Invention
|
Hiv protease inhibitors. The compounds encompassed by Formula I include compounds which are HIV p... |
|
Invention
|
Substituted phenyl spleen tyrosine kinase (syk) inhibitors. The invention provides certain substi... |
|
Invention
|
Hcv ns3 protease inhibitors. The present invention relates to hepatitis C virus (HCV) NS3 proteas... |
|
Invention
|
Non-nucleoside reverse transcriptase inhibitors.
Heteroaromatic compounds of Formula I:
Hetero... |
|
Invention
|
Pyrazolyl derivatives as syk inhibitors. The present invention provides novel pyrazole derivative... |
|
Invention
|
Imidazolyl analogs as syk inhibitors. The present invention provides novel imidazole analogs of F... |
|
Invention
|
Substituted pyridine spleen tyrosine kinase (syk) inhibitors. The invention provides certain subs... |
|
Invention
|
Cysteine protease inhibitors for the treatment of parasitic diseases. ascariasis, trichuriasis, s... |
2012
|
Invention
|
Hcv ns3 protease inhibitors. The present invention relates to macrocyclic compounds of formula (I... |
|
Invention
|
Hiv protease inhibitors. 7 are defined herein. The compounds encompassed by Formula I include com... |
|
Invention
|
Hiv protease inhibitors. Compounds of Formula I are disclosed: wherein A, R1, R2, R3, R4A, R4B, R... |
|
Invention
|
Scd inhibitors for the treatment of hcv. The present invention relates to methods of treating, pr... |
|
Invention
|
Bipyridylaminopyridines as syk inhibitors. The present invention provides novel pyrimidine amines... |
2011
|
Invention
|
Hiv protease inhibitors. 9 are defined herein. The compounds encompassed by Formula I include com... |
|
Invention
|
Sulfonamides as hiv protease inhibitors. 7 are defined herein. The compounds encompassed by Formu... |
|
Invention
|
Sulfonamides as hiv protease inhibitors. Compounds of Formula I are disclosed: wherein L, A, R1, ... |
|
Invention
|
Hiv protease inhibitors. Compounds of Formula I are disclosed wherein R1, R2, R3A, R3B, R4A, R4B,... |
|
Invention
|
Hiv integrase inhibitors. Tricyclic compounds of Formula I are inhibitors of HIV integrase and in... |
|
Invention
|
2-oxo-dihydropyridine non-nucleoside reverse transcriptase inhibitors. Heteroaromatic compounds o... |
|
Invention
|
Non-nucleoside reverse transcriptase inhibitors. Heteroaromatic compounds of Formula I: (I) are H... |
|
Invention
|
Non-nucleoside reverse transcriptase inhibitors. Heteroaromatic compounds of Formula I:
5 are de... |
|
Invention
|
Bridged lipoglycopeptides that potentiate the activity of beta-lactam antibacterials. The present... |
2010
|
Invention
|
Aminopyrimidines as syk inhibitors. The present invention provides novel pyrimidine amines of for... |
|
Invention
|
Spirocyclic piperidine derivatives useful as renin inhibitors.
Renin inhibitors which are spiroc... |
|
Invention
|
Spiro compounds useful as inhibitors of stearoyl-coenzyme a delta-9 desaturase. Heteroaromatic co... |
|
Invention
|
Cathepsin cysteine protease inhibitors for the treatment of various diseases.
The present invent... |
|
Invention
|
Renin inhibitors.
The present invention relates to biaryl piperidine-based renin inhibitor compo... |
|
Invention
|
Heterocyclic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase.
Heterocyclic com... |
|
Invention
|
Heterocyclic derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase.
Heterocyclic c... |
2009
|
Invention
|
Renin inhibitors.
The present invention relates to 3,4-substituted piperidinyl—based renin inhib... |
|
Invention
|
Transdermally administered aliskiren.
Dosage form of aliskiren, comprising a device for transder... |
|
Invention
|
Azetidine derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase.
Azetidine derivat... |
|
Invention
|
Indole derivatives as crth2 receptor antagonists. The compound (+) {7R-[[(4-fluorophenyl)sulfonyl... |
|
Invention
|
Azaindole derivatives as crth2 receptor antagonists. Compounds of formula I are antagonists of th... |
|
Invention
|
Indole derivatives as crth2 receptor antagonists. Compound of formula I are antagonists of the PG... |
|
Invention
|
3,4-substituted piperidine derivatives as renin inhibitors.
The present invention relates to 3,4... |
2008
|
Invention
|
Renin inhibitors.
The present invention relates to acyclic amino amide renin inhibitor compounds... |
1998
|
P/S
|
Pharmaceutical preparation to treat cancer. |
|
P/S
|
Allergy products namely, antihistamines, decongestants and steroid preparations to treat allergie... |
1995
|
P/S
|
Publications, namely newsletters, brochures, handouts, magazines, advertising materials, audio an... |
1994
|
P/S
|
Alkylating cytotoxic agent for the treatment of various types of cancer. |
1993
|
P/S
|
Foot care preparations, namely corn removal preparations, foot bath preparations, foot powders, f... |
1989
|
P/S
|
Pharmaceutical preparations namely, dermatological preparations, topical dermatologies, psychopha... |
1984
|
P/S
|
Pharmaceutical preparation, namely a non-steroidal, orally-active antiandrogen preparation. |
1983
|
P/S
|
Nonradioactive precursors for the production of radiopharmaceuticals; radiological contrast media... |
1978
|
P/S
|
Pharmaceutical preparations, namely a heparin solution. |
1969
|
P/S
|
Pharmaceutical preparations. |
1955
|
P/S
|
Pharmaceuticals. |
1953
|
P/S
|
Drugs, including pharmaceuticals and medicaments of animal, vegetable and mineral origin, toothpa... |
1950
|
P/S
|
A chemical compound to be used in the treatment or prevention of streptococcal, gonococcal, pneum... |
|
P/S
|
Medicinal estrogenic hormone preparation. |
1938
|
P/S
|
Pharmaceutical tablets for medicinal use. |
1936
|
P/S
|
Medicinal preparations recommended for the treatment of disordersof the stomach and digestive org... |